Montréal, Canada

Richard Béliveau

USPTO Granted Patents = 10 


 

Average Co-Inventor Count = 4.4

ph-index = 3

Forward Citations = 25(Granted Patents)


Location History:

  • Verdun, CA (2011)
  • Ile-des-Soeurs, CA (2016)
  • Montreal, CA (2011 - 2017)
  • Montréal, CA (2014 - 2023)

Company Filing History:


Years Active: 2011-2025

Loading Chart...
Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents

Title: **The Innovations of Richard Béliveau in Cancer Treatment**

Introduction

Richard Béliveau is a distinguished inventor based in Montréal, Canada, known for his significant contributions to the field of cancer treatment through innovative peptide compounds. With an impressive portfolio of nine patents, Béliveau's work focuses on the development of peptide conjugates designed to enhance chemotherapy efficacy.

Latest Patents

One of Richard Béliveau's latest patents is centered around "Peptide Compounds and Peptide Conjugates for the Treatment of Cancer through Receptor-Mediated Chemotherapy." This patent details the composition of peptide compounds and conjugate compounds, outlining processes, methods, and uses that specifically target cancer treatment. The compounds are particularly noted for their ability to increase cellular internalization, which is crucial for delivering therapeutic agents effectively. Notable examples from this patent include specific peptide sequences such as GVRAKAGVRNMFKSESY (SEQ ID NO: 9), GVRAKAGVRN(Nle)FKSESY (SEQ ID NO: 10), and YKSLRRKAPRWDAPLRDPALRQLL (SEQ ID NO: 11). Furthermore, these compounds may have at least one protecting group and/or at least one labeling agent attached, enhancing their functionality in clinical applications.

Career Highlights

Throughout his career, Béliveau has made substantial contributions at several renowned companies, notably Angiochem Inc. and Transfert Plus, S.e.c. His work in these organizations has played a crucial role in advancing research and development in the field of biochemistry and pharmacology, particularly relating to cancer therapies.

Collaborations

Richard Béliveau has collaborated with esteemed colleagues, including Michel Demeule and Anthony Regina. These partnerships have facilitated innovative research endeavors, significantly impacting the landscape of cancer treatment methodologies.

Conclusion

In summary, Richard Béliveau stands out as a prominent inventor whose work in the development of peptide-based cancer treatments reflects the power of innovation in medicine. His numerous patents serve as a testament to his dedication and expertise, paving the way for new therapeutic strategies that may improve patient outcomes. Through his career, Béliveau exemplifies the essence of innovation within the realm of healthcare, showcasing how inventive insights can lead to groundbreaking advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…